Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00342069 · ClinicalTrials.gov registry record
Prevalence of Ambivalence Regarding Prenatal Testing
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
NCT00342069: Completed study, sponsored by National Human Genome Research Institute (NHGRI).
NCT00342069 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00342069 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
Study Summary
This study will examine how women think and feel about prenatal testing (amniocentesis and chorionic villus sampling), how those thoughts and feelings change over time, and how they contribute to the decision whether or not to undergo prenatal testing. Prenatal diagnostic testing is offered to pregnant women at increased risk of carrying a baby affected with a genetic or chromosomal abnormality. Although these tests are well established, standard-of-care procedures, much remains unknown about how best to ensure that women make decisions about whether or not to undergo testing that are consistent with their beliefs and values. This study will explore the extent to which women are ambivalent about prenatal testing and determine how they might benefit from counseling aimed at improving the quality of their decision-making. Women 18 years of age and older who are scheduled for a prenatal genetics visit at clinics in Baltimore, MD; Minneapolis, MN; Binghamton, NY; Salt Lake City, UT; Washington, DC; and Bellevue, WA, and are at increased risk for having a baby with trisomy 21 (Down syndrome) may be eligible for this study. Participants complete two short questionnaires and a telephone interview about their thoughts and feelings regarding prenatal testing. The first two surveys examine the women's thoughts and feelings before and after prenatal counseling. Both are completed at the prenatal clinic-one before and one after the counseling session. The third survey is done by telephone a few weeks after the prenatal visit to find out if the participant did or did not have prenatal testing and learn about her thoughts and feelings regarding her decision.
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-12-17 |
| Est. Completion | 2007-12-10 |
What the finished NCT00342069 record still lists
NCT00342069 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00342069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00342069 about?
NCT00342069 is a clinical study titled "Prevalence of Ambivalence Regarding Prenatal Testing". This study will examine how women think and feel about prenatal testing (amniocentesis and chorionic villus sampling), how those thoughts and feelings change over time, and how they contribute to the decision whether or not to undergo prenatal testing. Prenatal diagnostic testing is offered to preg...
What is the current status of trial NCT00342069?
This trial is currently completed. The study started on 2004-12-17. Estimated completion is 2007-12-10.
Who is sponsoring clinical trial NCT00342069?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI